Kesavan Shan

2.7k total citations · 1 hit paper
20 papers, 2.1k citations indexed

About

Kesavan Shan is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Kesavan Shan has authored 20 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 8 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Surgery. Recurrent topics in Kesavan Shan's work include Cardiac Imaging and Diagnostics (8 papers), Cardiovascular Function and Risk Factors (8 papers) and Cardiac Fibrosis and Remodeling (5 papers). Kesavan Shan is often cited by papers focused on Cardiac Imaging and Diagnostics (8 papers), Cardiovascular Function and Risk Factors (8 papers) and Cardiac Fibrosis and Remodeling (5 papers). Kesavan Shan collaborates with scholars based in United States, United Kingdom and Brazil. Kesavan Shan's co-authors include A. Michael Lincoff, James B. Young, Yukihiro Seta, Douglas L. Mann, Hakan Oral, Biykem Bozkurt, Godwin Constantine, Mohan U. Sivananthan, Scott D. Flamm and William A. Zoghbi and has published in prestigious journals such as The Lancet, Circulation and Annals of Internal Medicine.

In The Last Decade

Kesavan Shan

20 papers receiving 2.0k citations

Hit Papers

Anthracycline-Induced Cardiotoxicity 1996 2026 2006 2016 1996 100 200 300 400 500

Peers

Kesavan Shan
Hal A. Skopicki United States
Thomas Guarnieri United States
Syed Wamique Yusuf United States
Robert S. Kernoff United States
G Bisi Italy
Kesavan Shan
Citations per year, relative to Kesavan Shan Kesavan Shan (= 1×) peers James T. Thackeray

Countries citing papers authored by Kesavan Shan

Since Specialization
Citations

This map shows the geographic impact of Kesavan Shan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kesavan Shan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kesavan Shan more than expected).

Fields of papers citing papers by Kesavan Shan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kesavan Shan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kesavan Shan. The network helps show where Kesavan Shan may publish in the future.

Co-authorship network of co-authors of Kesavan Shan

This figure shows the co-authorship network connecting the top 25 collaborators of Kesavan Shan. A scholar is included among the top collaborators of Kesavan Shan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kesavan Shan. Kesavan Shan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Constantine, Godwin, Kesavan Shan, Scott D. Flamm, & Mohan U. Sivananthan. (2004). Role of MRI in clinical cardiology. The Lancet. 363(9427). 2162–2171. 144 indexed citations
2.
Shan, Kesavan, Godwin Constantine, Mohan U. Sivananthan, & Scott D. Flamm. (2004). Role of Cardiac Magnetic Resonance Imaging in the Assessment of Myocardial Viability. Circulation. 109(11). 1328–1334. 110 indexed citations
3.
Shimoni, Sarah, Nikolaos G. Frangogiannis, C. Aggeli, et al.. (2003). Identification of Hibernating Myocardium With Quantitative Intravenous Myocardial Contrast Echocardiography. Circulation. 107(4). 538–544. 92 indexed citations
4.
Frangogiannis, Nikolaos G., Sarah Shimoni, Su Min Chang, et al.. (2002). Evidence for an Active Inflammatory Process in the Hibernating Human Myocardium. American Journal Of Pathology. 160(4). 1425–1433. 72 indexed citations
5.
Frangogiannis, Nikolaos G., Sarah Shimoni, Guofeng Ren, et al.. (2002). Active interstitial remodeling: an important process in the hibernating human myocardium. Journal of the American College of Cardiology. 39(9). 1468–1474. 92 indexed citations
6.
Shimoni, Sarah, Nikolaos G. Frangogiannis, C. Aggeli, et al.. (2002). Microvascular Structural Correlates of Myocardial Contrast Echocardiography in Patients With Coronary Artery Disease and Left Ventricular Dysfunction. Circulation. 106(8). 950–956. 80 indexed citations
7.
Nagueh, Sherif F., Sarah Shimoni, Kesavan Shan, et al.. (2001). Deceleration Time in Ischemic Cardiomyopathy. Circulation. 103(9). 1232–1237. 41 indexed citations
8.
Shan, Kesavan, Roger J. Bick, Brian J. Poindexter, et al.. (2000). Relation of tissue Doppler derived myocardial velocities to myocardial structure and beta-adrenergic receptor density in humans. Journal of the American College of Cardiology. 36(3). 891–896. 195 indexed citations
9.
Shan, Kesavan, Roger J. Bick, Brian J. Poindexter, et al.. (2000). Altered Adrenergic Receptor Density in Myocardial Hibernation in Humans. Circulation. 102(21). 2599–2606. 52 indexed citations
10.
Shan, Kesavan, Sherif F. Nagueh, & William A. Zoghbi. (1999). ASSESSMENT OF MYOCARDIAL VIABILITY WITH STRESS ECHOCARDIOGRAPHY. Cardiology Clinics. 17(3). 539–553. 10 indexed citations
11.
Lauer, Michael A., et al.. (1997). Increased left ventricular cavity size, not wall thickness, potentiates myocardial ischemia. American Heart Journal. 133(6). 691–697. 7 indexed citations
12.
Marwick, Thomas H., et al.. (1997). Incremental Value of Rubidium-82 Positron Emission Tomography for Prognostic Assessment of Known or Suspected Coronary Artery Disease. The American Journal of Cardiology. 80(7). 865–870. 95 indexed citations
13.
Shan, Kesavan, Karla Kurrelmeyer, Yukihiro Seta, et al.. (1997). The role of cytokines in disease progression in heart failure. Current Opinion in Cardiology. 12(3). 218–223. 76 indexed citations
14.
Shan, Kesavan, et al.. (1997). Anthracycline-Induced Cardiotoxicity. Annals of Internal Medicine. 126(10). 827–828. 42 indexed citations
15.
Seta, Yukihiro, Kesavan Shan, Biykem Bozkurt, Hakan Oral, & Douglas L. Mann. (1996). Basic mechanisms in heart failure: The cytokine hypothesis. Journal of Cardiac Failure. 2(3). 243–249. 351 indexed citations
16.
Shan, Kesavan, A. Michael Lincoff, & James B. Young. (1996). Anthracycline-Induced Cardiotoxicity. Annals of Internal Medicine. 125(1). 47–58. 589 indexed citations breakdown →
17.
Bozkurt, Biykem, Kesavan Shan, Yukihiro Seta, Hakan Oral, & Douglas L. Mann. (1996). Tumor necrosis factor-? and tumor necrosis factor receptors in human heart failure. Heart Failure Reviews. 1(3). 211–219. 10 indexed citations
18.
Marwick, Thomas H., Kesavan Shan, Raymundo T. Go, William J. MacIntyre, & Michael S. Lauer. (1995). Use of positron emission tomography for prediction of perioperative and late cardiac events before vascular surgery. American Heart Journal. 130(6). 1196–1202. 7 indexed citations
19.
Shan, Kesavan, et al.. (1995). The diagnosis of prosthetic valve endocarditis by echocardiography.. PubMed. 7(1). 7–12. 11 indexed citations
20.
Williams, Michael, et al.. (1995). Dobutamine vs dipyridamole echo for risk stratification before vascular surgery. Journal of the American Society of Echocardiography. 8(3). 406–406. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026